Update: NovoCure has priced its IPO at $165 million.
With the $165 million (initially targeted at $300 million) NovoCure IPO, the Symetis $83 million IPO and big fundings for Auris Surgical Robotics ($150 mil.), and CeQur ($100 mil.), medtech fundings for the month of September flirted with the $1 billion mark, ending at
$997 million $862 million.
The complete list of fundings is shown at link.